medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2006, Número 2

<< Anterior Siguiente >>

Rev Inst Nal Enf Resp Mex 2006; 19 (2)


Manejo quirúrgico del cáncer de pulmón. Hechos y algunas reflexiones

Ibarra-Pérez C

Idioma: Español
Referencias bibliográficas: 41
Paginas: 143-147
Archivo PDF: 119.11 Kb.


RESUMEN

El carcinoma broncogénico de células no pequeñas (CBCNP) en etapas I y II es tributario de resección completa, pero cada vez existe más evidencia de que la terapia de inducción preoperatoria y la adyuvancia posoperatoria pueden prolongar la sobrevida de enfermos en etapas IB y II. Algunos enfermos en la etapa IIIA debe recibir inducción y revalorar el mediastino por fusión TC/PET o remediastinoscopía antes de planear resección. Las etapas IIIB y IV no son operables, excepto casos muy seleccionados. Se hacen reflexiones a propósito del acceso de los enfermos de países en desarrollo a los nuevos avances médicos, farmacológicos y tecnológicos, del control del tabaquismo y de algunos aspectos éticos relacionados con el tratamiento médico y la cirugía del CBCNP.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Toloza EM, Harpole L, McCrory DC. Noninvasive staging of non-small cell lung cancer. a review of the current evidence. Chest 2003;123(1 Suppl):137-146.

  2. Silvestri GA, Tanoue LT, Margolis ML, Barker J, Detterbeck F. The noninvasive staging of non-small cell lung cancer: the guidelines. Chest 2003;123(1 Suppl):147-156.

  3. Gamez C, Rosell R, Fernandez A, et al. PET/CT fusion scan in lung cancer: current recommendations and innovations. J Thorac Oncol 2006;1:74-77.

  4. Toloza EM, Harpole L, Detterbeck F, McCrory DC. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest 2003; 123(1 Suppl): 157-166.

  5. Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA. Invasive staging: the guidelines. Chest 2003;123(1 Suppl):167-175.

  6. Murthy SC, Rice TW. Thoracic incisions. In: Pearson FG, Cooper JD, Deslauriers J, et al, editors. Thoracic surgery. 2ª ed. New York: Churchill Livingstone; 2002.p.120-138.

  7. Fry WA. Thoracic incisions. In: Shields TW, LoCicero J, Ponn RB, Rusch VW, editors. General thoracic surgery. 6ª ed. Philadelphia: Lippincott Williams & Wilkins;2005.p.411-419.

  8. Ponn RB, LoCicero III J, Daly BDT. Surgical treatment of non-small cell lung cancer. In: Shields TW, LoCicero III J, Ponn RB, Rusch VW, editors. General thoracic surgery. 6a ed. Philadelphia: Lippincott Williams & Wilkins; 2005.p.1548-1587.

  9. Jett JR, Scott WJ, Rivera MP, Sause WT. Guidelines on treatment of stage IIIB non-small cell lung cancer. Chest 2003;123(1 Suppl):221-225.

  10. Detterbeck FC, Jones DR, Kernstine KH, Naunheim KS. Special treatment issues. Chest 2003;123(1 Suppl): 244-258.

  11. Ibarra-Pérez C, Kelly-García J, Fernández-Corzo MA. Tratamiento del cáncer broncogénico de células no pequeñas localmente avanzado, etapa IIIB, con énfasis en la cirugía. Rev Inst Nal Enf Resp Mex 2000;13:222-226.

  12. Downey RJ. Non-small cell lung cancer with a solitary hematogenous metastasis. Thorac Surg Clin 2004;14: 265-269.

  13. Pisters KMW. Multimodality management of early-stage lung cancer. In: Franco KL, Putnam JB, editors. Advanced therapy in thoracic surgery . 2a ed. Hamilton:BC Decker;2005.p.61-67.

  14. Berghmans T, Paesmans M, Meert AP, et al. Survival improvement in resectable non-small cell lung cancer with (neo) adjuvant chemotherapy: results of a meta-analysis of the literature. Lung Cancer 2005;49:13-23.

  15. Booth CM, Shepherd FA. Adjuvant chemotherapy for resected non-small cell lung cancer . J Thorac Oncol 2006;1:180-187.

  16. Diagnosis and management of lung cancer: ACCP evidence-based guidelines. Chest 2003;123(1 Suppl).

  17. Robinson LA, Wagner H Jr, Ruckdeschel JC. Treatment of stage IIIA non-small cell lung cancer. Chest 2003;123(1 Suppl):202-220.

  18. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-smallcell lung cancer. Lung Cancer 1998;21:1-6.

  19. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;26:7-14.

  20. De Waele M, Hendriks J, Lauwers P, et al. Nodal status at repeat mediastinoscopy determines survival in non-small cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg 2006;29:240-243.

  21. 21.Feins RH. Clinical trials in lung cancer: truth, justice, and the American way. Ann Thorac Surg 2000;70: 1139-1141.

  22. Ginsberg RJ. Non-small cell lung cancer. Surgical management. In: Pearson FG, Coper JD, Deslauriers J, et al, editors. Thoracic surgery. 2a ed. New York: Churchill-Livingstone;2002.p.837-859.

  23. Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg 2005;80:2051-2056.

  24. Kuzdzal J, Zielinski M, Papla B, et al. Transcervical extended mediastinal lymphadenectomy-the new operative technique and early results in lung cancer staging. Eur J Cardiothorac Surg 2005;27:384-390.

  25. Smulders SA, Smeenk FW, Janssen-Heijnen ML, Wielders PL, de Munck DR, Postmus PE. Surgical mediastinal staging in daily practice. Lung Cancer 2005;47:243-251.

  26. Goodney PP, Lucas FL, Stukel TA, Birkmeyer JD. Surgeon specialty and operative mortality with lung resection. Ann Surg 2005; 241:179-184.

  27. Martin-Ucar AE, Waller DA, Atkins JL, Swinson D, O’Byrne KJ, Peake MD. The beneficial effects of specialist thoracic surgery on the resection rate of non-smallcell lung cancer. Lung Cancer 2004;46:227-232.

  28. Wright G. Letter to the Editor. Lung Cancer 2005; 47:425-426.

  29. Allen MS, Darling GE, Pechet TT et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1019.

  30. Rami-Porta R, Wittekind C, Goldstraw P, et al. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 2005; 49:25-33.

  31. Kuzdzal J, Zielinski M. Letter to the Editor. Lung Cancer 2005; 51:131-132.

  32. Rami-Porta, Wittekind C, Goldstraw P. Reply to letter to the Editor. Lung Cancer 2005;51:133-134.

  33. Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg 2000; 70:358-365.

  34. Wu Y, Huang ZF, Wang SY, Yang XN, Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002;36:1-6.

  35. Passlick B, Kubuschock B, Sienel W, Thetter O, Pantel K, Izbicki JR. Mediastinal lymphadenectomy in non-small cell lung cancer: effectiveness in patients with or without nodal micrometastases —results of a preliminary study—. Eur J Cardiothorac Surg 2002; 21:520-526.

  36. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 2003; 21:1029-1034.

  37. Lardinois D, Suter H, Hakki H, Rousson V, Betticher D, Ris HB. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer. Ann Thorac Surg 2005; 80:268-274.

  38. Ludwig MS, Goodman M, Miller DL, Johnstone PA. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer. Chest 2005;128:1545-1550.

  39. Allen MS. Mediastinal lymph node dissection for nonsmall cell lung cancer. J Thorac Cardiovasc Surg 2005;130:241-242.

  40. Scagliotti GV, Novello S. Current development of adjuvant treatment of non-small cell lung cancer. Clin Lung Cancer 2004; 6(Suppl 2):63-70.

  41. 41.Ito M, Minamiya Y, Kawai H, et al. Intraoperative detection of lymph node micrometastasis with flow cytometry in non-small cell lung cancer. J Thorac Cardiovasc Surg 2005;130:753-758.




2020     |     www.medigraphic.com